Teva Pharmaceutical 2016-2019 Financial Outlook

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Teva Pharmaceutical Industries' preliminary financial outlook and guidance for 2016-2019, presented July 2016. The presentation outlines management expectations including the impact of the pending Allergan generics acquisition and operational strategy through 2019.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Teva Pharmaceutical Industries

View all →

Teva Pharmaceutical Industries Investor Presentation — April 2021

investor_presentation

37 Pages

Teva Pharmaceutical Industries Investor Presentation — August 2017

investor_presentation

Similar investor_presentations from other companies

Browse all →

Xerox Holdings Investor Presentation — April 2017

investor_presentation

29 Pages

Xerox Holdings Corp.

Evolus Inc. Investor Presentation June 2022

investor_presentation